Kalo te përmbajtja
  • EN
  • SQ
  • IT
  • FR
  • ES
  • DE
  • EL
VA-NEWS VA-NEWS
  • Home
  • News
  • Opinion
  • Health
  • Technology
  • Sport
  • Lifestyle
  • Entertainment
  • Travel
LIVE
Navigation

VA-NEWS

  • Home
  • News
  • Opinion
  • Health
  • Technology
  • Sport
  • Lifestyle
  • Entertainment
  • Travel
Shortcuts
Home Latest
LIVE
Gjuha
  • EN
  • SQ
  • IT
  • FR
  • ES
  • DE
  • EL

Search news

  1. Kryefaqja
  2. Health
  3. Beyond BMI: New obesity definition may better identify health risks
Health

Beyond BMI: New obesity definition may better identify health risks

• November 15, 2026 • 9 min read • 👁 1
◉ WhatsApp 𝕏 X
News

Evidence suggests that roughly one in seven people are living with obesity, which can increase the risk of several health conditions, including cardiovascular disease, type 2 diabetes, high blood pressure, and certain cancers.

While body mass index (BMI) can help estimate body fat and the risk of fat-related diseases, it does not properly measure body fat or account for its distribution throughout the body, which may mislead healthcare providers and cause them to underestimate or overestimate an individual’s risk.

Now, a new study suggests a more comprehensive diagnostic approach may be more effective than BMI alone at identifying those with excess body fat and assessing their health risk.

The large international study, published in Nature, supports a diagnostic framework proposed by a Lancet Diabetes & Endocrinology Commission, which distinguishes between clinical and preclinical obesity to help healthcare professionals provide more personalized treatment and prevention strategies.

The researchers analyzed health data from 844,108 adults across China, the United Kingdom, the United States, and Spain, comparing traditional BMI-based obesity classifications with the new diagnostic framework.

They found that BMI alone could misclassify obesity in both directions. When researchers incorporated waist measurements alongside BMI, they found that BMI alone missed obesity-level body fat in up to 8.6% of participants, and BMI inadequately classified up to 3.1% of people as having obesity across the study groups.

The researchers also found that obesity was associated with an increased risk of death when identified using BMI alongside waist measurements, but not when BMI was used alone.

The distinction between clinical and preclinical obesity also revealed important differences in health outcomes.

Read more:Experts issue new recommendations for treating shift work disorder

Clinical obesity accounted for approximately 23% to 31% of all obesity cases and had an overall population prevalence of 5.6% to 10.9%. People with clinical obesity had a substantially higher risk of death, whereas preclinical obesity was associated with only a modest increase in mortality risk.

Notably, most people with preclinical obesity did not progress to clinical obesity during the follow-up period. Across the study groups, between 77% and 91% of people with preclinical obesity remained free of clinical obesity over 10 years.

“It tells us that preclinical obesity is not harmless but also not active disease, and for most people it is not a fast track to illness,” senior study author Francesco Rubino, MD, chair of Metabolic and Bariatric Surgery at King’s College London, and honorary consultant surgeon at King’s College Hospital, emphasized to Medical News Today.

“Most people stayed stable over a decade, but a meaningful minority did progress. That is exactly why we need to assess the individual, not just the label. Two people with preclinical obesity can have very different futures depending on other factors such as: age, family history, or the presence of other risk factors such as prediabetes,” Rubino explained.

“Individual risk assessment lets doctors match care to that risk: closer monitoring and more active prevention, including by drugs or surgery for those most likely to progress, and lifestyle support and monitoring for others. It’s important to be clear that ‘stable’ doesn’t mean ‘ignore’. Preclinical obesity still carries some extra risk, and some people will benefit from treatment, including medication, to prevent illness.”

– Francesco Rubino, MD

The researchers used a statistical method to account for the background risk of organ dysfunction among people without obesity. This helped them distinguish health problems potentially attributable to excess body fat from those arising for other reasons.

“The most important finding is that the risk to health follows excess body fat, and above all the harm that fat does to the organs, not the number on the scale,” Rubino highlighted to MNT.

“People labelled overweight or as having obesity by BMI but without excess fat had no higher risk of death. By contrast, people whose excess fat was already affecting their organs, which we call clinical obesity, had the highest risk,” he added.

Read more:Depression: Escitalopram may be best option for long-term use

“For people living with obesity, this matters a great deal. It means a diagnosis can finally reflect their actual health, not just their size. Using BMI some people may be told they have a disease when they don’t,” said Rubino. “Others are told they are merely ‘overweight’ when they actually have ongoing illness and need urgent care. A more accurate diagnosis means the right care for the right person.”

The new framework uses a two-step approach to diagnosing obesity.

Rather than relying on BMI alone, healthcare professionals should combine BMI with additional body far measurements, such as waist circumference and waist-to-height ratio.

These measurements can help identify excess body fat and provide information about abdominal fat distribution.

Once excess body fat has been established, the framework classifies obesity into two categories.

Clinical obesity refers to a condition in which excess body fat causes illness by impairing the function of organs or the body’s ability to carry out everyday activities. People with clinical obesity may experience obesity-related health complications and require treatment to manage the effects of the condition.

Preclinical obesity refers to excess body fat associated with an increased risk of future health problems, but without current evidence of impaired organ or whole-body function. People with preclinical obesity may benefit from preventive measures and monitoring, depending on their individual health risks.

This distinction aims to ensure that treatment is appropriate to a person’s current health status rather than being determined by BMI alone.

Read more:Thanks to American oligarchy, Jensen Huang’s midlife crisis is a problem for all of us | Moira Donegan | The Guardian

“Both involve excess body fat. The difference is whether that fat is already making someone ill,” Rubino told MNT.

“Clinical obesity means excess fat is already affecting how the organs or the body work. Examples are breathlessness, heart failure, or joint problems that limit mobility. It is an active illness, like any other chronic disease,” he explained.

“Preclinical obesity means excess fat with organs still working normally. There is a higher risk for the future, but no illness yet,” the researcher continued.

“This changes diagnosis in two ways. First, BMI becomes only a first screening step. Excess fat is then confirmed with simple measures such as waist size. Second, doctors assess whether the organs are affected, which is how every other disease is diagnosed. It’s the same logic as prediabetes and diabetes, or a bowel polyp and bowel cancer.”

– Francesco Rubino, MD

“Preclinical obesity is a risk. Clinical obesity is an illness. Telling them apart is what a diagnosis is for,” he emphasized.

The researchers believe the findings could have important implications for how healthcare professionals diagnose and manage obesity.

Under a BMI-based approach, people may be classified as having obesity without considering whether excess body fat is already affecting their health. This could potentially result in some people receiving unnecessary treatment, while others with obesity-related health complications may not receive sufficient care.

Read more:Levante 2-4 Barcelona (Sep 13, 2026) Game Analysis – ESPN

The new framework aims to support more personalized treatment by distinguishing between people who have an active disease and those who have an increased risk of developing one. The new definition could make personalized and proportionate care more achievable.

For example, the researchers note that preclinical obesity should not automatically be treated as an active disease, but neither should it be considered harmless. Some people may benefit from preventive treatment, but the intensity of intervention should reflect their individual risk.

Rubino suggests the new framework could help prevent unnecessary treatment for some people while ensuring those with obesity-related complications receive appropriate care:

“Any blanket approach gets someone wrong: If obesity is always a disease: you risk over-treating people who aren’t ill, or who don’t even have excess fat. If obesity is only a risk factor: you risk under-treating people who are already ill and need timely care.”

“The framework allows care to be proportionate. People with clinical obesity have an active disease and should get prompt, effective treatment, which may include medication or surgery. People with preclinical obesity need care focused on prevention of harm before it happens, matched to their individual risk. That can also include treatment when risk is high,” he noted.

“This matters even more now, with powerful but costly new obesity medicines. It helps make sure they reach the people who need them most, without exposing others to treatment they may not need,” the study author added.

The findings highlight the importance of assessing more than just a person’s weight when evaluating their health.

For those living with obesity, a diagnosis based on additional measurements and evidence of organ function could provide a clearer picture of their individual health risks.

Read more:Could longer exposure to estrogen benefit brain health?

It may also help healthcare professionals identify those requiring treatment for existing obesity-related complications and those who may benefit from monitoring and preventive interventions.

“First, your health can’t be judged by your weight alone. BMI is a rough measure of size. It doesn’t tell you, or your doctor, whether you are ill,” noted Rubino.

“Second, if you have obesity, ask for a proper assessment. That means measuring your waist as well as your weight, and checking how your body is actually working. You deserve a diagnosis based on your health, as with any other medical condition,” he continued.

“Third, a diagnosis of preclinical obesity doesn’t mean ‘wait and see,’ and clinical obesity is not a personal failing. Clinical obesity is a disease that deserves timely, effective treatment, without blame or stigma. Preclinical obesity is a chance to act early and protect your health,” Rubino explained.

“Most importantly, people with obesity, like everyone else, deserve proportionate care, matched to their needs. No less, and no more. This framework makes this possible,” he concluded.

The researchers suggest that the findings support wider adoption of the new framework to improve obesity care and health policies internationally.

The results add to evidence indicating that moving beyond BMI alone could help healthcare professionals make more accurate assessments of obesity and better match treatment to individual needs. However, further work will be important to support the implementation of the framework in routine clinical practice.

Read also
Health

Depression: Escitalopram may be best option for long-term use

Health

Cardiometabolic disease: How sleep could support brain health

Tags: #AMP #Ask #China #Family #Has #Health #Participants #Spain #Will

Journalist

From the same category
  • Depression: Escitalopram may be best option for long-term use
  • Cardiometabolic disease: How sleep could support brain health
  • Knee osteoarthritis: 2 trials link new weight-loss drug to pain relief
  • Could longer exposure to estrogen benefit brain health?
  • Experts issue new recommendations for treating shift work disorder
From the same tags
  • Pochettino’s USMNT tenure had ups, downs and an ever-present mercenary feel
  • Corporate Democrats are weaponizing identity politics to smear progressives | Arwa Mahdawi | The Guardian
  • Tearful Pochettino on USMNT exit: Toughest decision of my career
  • Depression: Escitalopram may be best option for long-term use
  • What the choice between Chuck Schumer and Chris Van Hollen for Senate leader is all about | Bernie Sanders | The Guardian
Më të lexuarat — 48h
  1. 01
    Opinion What the choice between Chuck Schumer and Chris Van Hollen for Senate leader is all about | Bernie Sanders | The Guardian 2 lexime · 1 day ago
  2. 02
    Health Depression: Escitalopram may be best option for long-term use 2 lexime · 1 day ago
  3. 03
    Football Tearful Pochettino on USMNT exit: Toughest decision of my career 1 lexime · 1 day ago
  4. 04
    Health Beyond BMI: New obesity definition may better identify health risks 1 lexime · 3 hours ago
  5. 05
    Football Pochettino’s USMNT tenure had ups, downs and an ever-present mercenary feel 1 lexime · 3 hours ago
Similar articles
Health

Depression: Escitalopram may be best option for long-term use

Antidepressants are some of the most commonly prescribed drugs in the United States, with active prescriptions lasting anywhere…

• 1 day ago • 5 min read
Health

Cardiometabolic disease: How sleep could support brain health

Getting enough quality sleep could help improve cognitive function in people with type 2 diabetes, heart disease, or…

• 2 days ago • 5 min read
Health

Knee osteoarthritis: 2 trials link new weight-loss drug to pain relief

The knee is the joint most commonly affected by osteoarthritis, a condition in which the cartilage in joints…

• 3 days ago • 6 min read
VA-NEWS VA-NEWS

Modern portal of reliable, independent and multilingual news. Accurate information, every day.

  • Health
  • Lifestyle
  • News
    • World
  • Opinion
  • Sport
    • Football
  • uncategorized
  • © 2026 VA News. Made with ♥ in Albania
    ⌂ Home ◷ Latest

    Powered by CookieAdmin
    Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.
    None
    Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.
    None
    Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.
    None
    Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.
    None
    Unclassified cookies are cookies that we are in the process of classifying, together with the providers of individual cookies.
    None
    Powered by CookieAdmin